glp-1 for iih Metabolic pathogenesis and treatment in IIH. is most prevalent in The Benefits and Risks of

GLP-1 receptors are expressed in key reward-related brain regions , including: The ventral tegmental area (VTA) and nucleus accumbens , which form the core of the mesolimbic dopamine pathway The prefrontal cortex , involved in executive function and impulse control The amygdala , which processes emotional salience and stress responses The prevailing hypothesis suggests that GLP-1 receptor activation may modulate dopamine signalling in reward circuits

On a regular schedule

Research indicates that gastroparesis may be more common in patients who take GLP-1 drugs like Ozempic than in people who take other weight loss drugs

doi: 10.1016/j.regpep.2014.04.003 [DOI] [PubMed] [Google Scholar] 179

The Wegovy pill is a different product